Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Liquid alternatives navigate choppy markets

Thursday, September 13, 2012

amb
Jon Sundt
Bailey McCann, Opalesque New York:

Liquid alternatives are gaining more traction with investors seeking both returns and the ability to react nimbly to a changing market environment. The sideways market has pushed some investors out of more illiquid investment options, and into liquid alternatives as a means of navigating risk and exposure during this uncertain time.

Liquid alternatives give investors the same access to hedged strategies like long/short equity, with the ability to get in and out quickly. One of the biggest names in this space is Altegris, which offers liquid alternatives for long/short equity, global macro and managed futures. Altegris aims to provide lower volatility and uncorrelated returns by crafting products through a research driven approach that pulls together a mix of top-tier managers in order to drive consistent returns even in choppy markets.

"We are in unprecedented territory in the US, EU, Asia - trends will return as this shakes out. The global investment environment has been extraordinarily difficult, characterized by a lack of sustainable trends in aggregate," says Jon Sundt, CEO, Altegris in an interview with Opalesque. "The EU is 20-25% of global GDP, with unprecedented debt to GDP. The US needs austerity, we need good monetary policy. The play can't go on forever, the actors are going to get t......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its